Skip to content
Tuesday, August 16, 2022
Latest:
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • MindMed Announces the Publication of New Data on Personalized MDMA Dosing
  • Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
  • CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia(TM) in Hungary
Biotech Market News

Biotech Market News

Know First, Act First

  • Fiscal
  • General
  • Covid
  • Cannabis & Psych
  • International
  • Trending

BIOTCHNO

BIOTCHNO International 

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

February 11, 2021April 14, 2021 Bachittar

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China  

Read more
BIOTCHNO Trending 

NG Energy to Re-Enter Istanbul-1 Well in the Maria Conchita Block in February 2021

February 11, 2021April 8, 2021 Bachittar

NG Energy to Re-Enter Istanbul-1 Well in the Maria Conchita Block in February 2021 Canada NewsWire VANCOUVER, BC , Feb.

Read more
BIOTCHNO General 

SQI Diagnostics Announces Proposed Insider Sales and Warrant Exercises to Fund Company

February 10, 2021April 14, 2021 Bachittar

  Canada NewsWire Company Expects to Use Proceeds for Clinical Development and Commercialization Efforts TORONTO,Feb. 10, 2021/CNW/ – SQI Diagnostics Inc.

Read more
BIOTCHNO Fiscal 

Neptune to Report Fiscal 2021 Third Quarter Financial Results on February 15, 2021

February 8, 2021April 15, 2021 Bachittar

  Canada NewsWire LAVAL, QC, Feb. 8, 2021/CNW Telbec/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT)

Read more
BIOTCHNO Trending 

Transnetyx Announces Acquisition of BrainBits®

February 8, 2021April 8, 2021 Bachittar

Transnetyx Announces Acquisition of BrainBits® Canada NewsWire MEMPHIS, Tenn. , Feb. 8, 2021 /CNW/ — Transnetyx, a global leader in

Read more
BIOTCHNO Cannabis & Psych 

MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics

February 2, 2021April 15, 2021 vanessa

Canada NewsWire J.R. Rahn to become sole CEO;Perry Dellelceto become Chair;Stephen Hurstretires as executive but remains on board;Stanley Glickretires as

Read more
BIOTCHNO Fiscal 

Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics

January 27, 2021June 2, 2021 vanessa

Canada NewsWire Company focused on continued advancement of its small molecule therapeutics platform including development of fezagepras and evaluating strategic

Read more
BIOTCHNO General 

The Valens Company Announces CDN$35 Million Bought Deal Offering of Units and Filing of Preliminary Base Shelf Prospectus

January 25, 2021April 14, 2021 vanessa

Canada NewsWire /NOT FOR DISTRIBUTION TOUNITED STATESNEWS WIRE SERVICES OR FOR DISSEMINATION INTHE UNITED STATES./ KELOWNA, BC,Jan. 25, 2021/CNW/ –

Read more
BIOTCHNO International 

Vertical Field Signs Pilot Agreement to Install Vertical Farms in the United Emirates

January 20, 2021April 14, 2021 vanessa

Canada NewsWire The agreement with Emirates Smart Solutions & Technologies (ESST) is expected to expand to a large-scale multi-million dollar

Read more
BIOTCHNO General 

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer

January 13, 2021April 14, 2021 vanessa

Canada NewsWire HOUSTONandVANCOUVER, BC,Jan. 13, 2021/CNW/ –ESSA Pharma Inc. (Nasdaq: EPIX) (“ESSA” or the “Company”), a clinical-stage pharmaceutical company focused

Read more
  • ← Previous
  • Next →

International

Oil-Dri Announces Patent in Korea for Novel Mineral-Based Feed Additive Formulation for Modern Animal Protein Production
BIOTCHNO International 

Oil-Dri Announces Patent in Korea for Novel Mineral-Based Feed Additive Formulation for Modern Animal Protein Production

February 11, 2021April 8, 2021 Bachittar

Oil-Dri Announces Patent in Korea for Novel Mineral-Based Feed Additive Formulation for Modern Animal Protein Production CHICAGO, Feb. 11, 2021

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
BIOTCHNO International 

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

February 11, 2021April 14, 2021 Bachittar
Vertical Field Signs Pilot Agreement to Install Vertical Farms in the United Emirates
BIOTCHNO International 

Vertical Field Signs Pilot Agreement to Install Vertical Farms in the United Emirates

January 20, 2021April 14, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057